Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis
Authors:
Open Access
- 27 September 2001
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 15 (9) , 1375-1384
Abstract
Background: Reflux of duodeno‐gastric juice into the oesophagus appears to be involved in the pathogenesis of both reflux oesophagitis and oesophageal adenocarcinoma. Although proton pump inhibitors have been shown to decrease acid reflux and heal oesophagitis, their effect on biliary reflux and motility is less clear. Aim: To investigate whether pantoprazole also reduces bile reflux and whether this is paralleled by a change in oesophageal motility. Methods: Combined 24‐h measurements of intraoesophageal bilirubin concentration, pH and pressure were performed in 18 symptomatic patients with endoscopically proven reflux oesophagitis before and on day 28 of treatment with pantoprazole, 40 mg/day, under standardized conditions. A reflux symptom score was determined initially and every 2 weeks thereafter. After 56 days on medication, a control endoscopy was performed. Results: The symptom score and the acid and bile reflux improved significantly, whereas the motility parameters did not change during the study period. Helicobacter pylori‐positive patients had a significantly higher bile reflux time (32.1 ± 4.3%) than H. pylori‐negative patients (16.3 ± 3.1%) (P=0.009). The endoscopic healing rate was 89%. The cough symptoms disappeared in three of four patients. Conclusions: The proton pump inhibitor pantoprazole decreases both acid and bile reflux. The decrease of bile reflux cannot be explained by increased oesophageal clearance as oesophageal motility did not improve with therapy. Interestingly, H. pylori infection of the stomach was associated with higher levels of oesophageal bile reflux.Keywords
This publication has 60 references indexed in Scilit:
- Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitisAlimentary Pharmacology & Therapeutics, 1999
- Double reflux: double troubleGut, 1999
- Weight Loss Has an Independent Beneficial Effect on Symptoms of Gastro-oesophageal Reflux in Patients Who Are OverweightScandinavian Journal of Gastroenterology, 1999
- Contribution of acid and duodenogastrooesophageal reflux to oesophageal mucosal injury and symptoms in partial gastrectomy patientsGut, 1997
- Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockadeDigestive Diseases and Sciences, 1996
- Mixed Reflux of Gastric and Duodenal Juices Is More Harmful to the Esophagus than Gastric Juice AloneAnnals of Surgery, 1995
- Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagusBritish Journal of Surgery, 1995
- Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcerAlimentary Pharmacology & Therapeutics, 1994
- Effect of pantoprazole on 24‐h intragastric pH and serum gastrin in humans.Alimentary Pharmacology & Therapeutics, 1994
- Long-term ambulatory enterogastric reflux monitoringDigestive Diseases and Sciences, 1993